RhyGaze is a biotechnology company developing gene therapies for vision restoration in retinal diseases.

Alesta Therapeutics is a biotechnology company developing oral small molecule therapies for rare diseases.

Citryll is a biotech company developing therapies for immune-mediated inflammatory diseases, focusing on a monoclonal antibody targeting Neutrophil Extracellular Traps (NETs).

LoQus23 Therapeutics develops small molecule drugs to halt DNA instability and slow neurodegeneration in triplet repeat diseases like Huntington's disease.

Epsilogen specializes in developing immunoglobulin E (IgE) antibodies for cancer treatment, including the first therapeutic IgE antibody to enter clinical trials.

AstronauTx is a London-based biotech company that develops small-molecule drugs for the treatment of Alzheimer's disease, and has raised £48 million ($61 million) in Series A financing to advance its drug portfolio, including conducting a clinical study for its lead program.

FORE Biotherapeutics is a precision oncology company that focuses on the clinical development of plixorafenib, a novel small-molecule inhibitor for treating BRAF-altered tumors.